Curon Biopharma
Shanghai
About Curon Biopharma
Curon Biopharma is a developer of drugs intended designed for immuno-oncology therapies. The company's drugs consist of multiple class-leading cancer immunotherapeutic agents in the world that could address the shortcomings of current cancer treatment paradigm, enabling a physician to provide advanced cancer immunotherapies to their patients.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $150.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Jul 2018)
- Website: curonbiopharma.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/curon-biopharma-94423 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.